HAE

HAEMONETICS CORP

Healthcare | Mid Cap

$1.23

EPS Forecast

$356

Revenue Forecast

Announcing earnings for the quarter ending 2024-12-31 soon
ARAYAccuray IncIARTIntegra Lifesciences Holdings CorpMDXGMimedx Group IncMMSIMerit Medical Systems IncTNDMTandem Diabetes Care IncGMEDGlobus Medical IncPODDInsulet CorpIRTCIrhythm Technologies IncNVRONevro CorpICUIIcu Medical Inc